Exhibitors Search
RayMed Co., Ltd.
Booth no.
H50
|
Exhibition
|
|KOREA LIFE SCIENCE |
|---|---|
|
Country
|
| Korea, South |
|
Address
|
|75 Nowon-ro, Nowon-gu, Seoul, Republic of Korea |
|
Tel
|
|+82-2-975-1181 |
|
Exhibits
|
| Imaging-Based Dosimetry-Driven Precision Radiopharmaceutical Therapy Platform |
|
Company Type
|
| Pharmaceutical / Drug Development Company , Biotech Venture / Startup , Digital Health / Medical Device Company |
Exhibitor Information
RayMed is a biotechnology company developing radiopharmaceutical therapies (RPTs) based on its RPT-specialized AI drug development platform and dosimetry technologies. Through AI-based candidate optimization and dosimetry-based efficacy and toxicity assessment, RayMed aims to improve the efficiency and probability of success in RPT drug development. The company is also commercializing dosimetry software for Y-90 transarterial radioembolization (TARE).
Exhibit Description
1. Radiopharmaceutical Drug Development:
RayMed leverages RPT-specialized AI and dosimetry technologies to optimize drug candidates and quantitatively assess efficacy and toxicity at the preclinical stage, enabling more efficient and effective development of radiopharmaceutical therapies.
2. Dosimetry Software Sales:
RayMed has completed the development of β RayVision(Y-90), a dosimetry software solution for Y-90 transarterial radioembolization (TARE) in liver cancer treatment that supports patient-specific radiation dose and treatment response analysis. The company is pursuing commercialization with healthcare institutions and partners in Korea and overseas.
RayMed leverages RPT-specialized AI and dosimetry technologies to optimize drug candidates and quantitatively assess efficacy and toxicity at the preclinical stage, enabling more efficient and effective development of radiopharmaceutical therapies.
2. Dosimetry Software Sales:
RayMed has completed the development of β RayVision(Y-90), a dosimetry software solution for Y-90 transarterial radioembolization (TARE) in liver cancer treatment that supports patient-specific radiation dose and treatment response analysis. The company is pursuing commercialization with healthcare institutions and partners in Korea and overseas.
Individual Exhibit/Technology Introduction (Detailed)
-
Product Name : β RayVision(Y-90)β RayVision(Y-90) is a patient-specific medical image analysis software solution for Y-90 transarterial radioembolization (TARE). Based on patient imaging data such as CT, SPECT/CT, and PET/CT, it analyzes key regions including the liver and tumors and quantitatively calculates absorbed dose.
KYUNGYON EXHIBITION CORP.
